1. American College of Obstetricians and Gynecologists Committee on Ethics. (2009). ACOG committee opinion no. 439. Informed consent. Obstetrics and Gynecology, 114(2), 401–408. doi: 10.1097/AOG.0b013e3181b48f7f .
2. American College of Obstetricians and Gynecologists Committee on Genetics. (2011). ACOG committee opinion no. 486. Update on carrier screening for cystic fibrosis. Obstetrics and Gynecology, 117(4), 1028–31. doi: 10.1097/AOG.0b013e31821922c2 .
3. Avard, D., & Harmsen, E. (2010). Informed consent and multiplex genetic screening. In: Encyclopedia of life sciences (pp. 1–6). Chichester: Wiley. doi: 10.1002/9780470015902.a0005642.pub2 .
4. Bekker, H., Thornton, J. G., Airey, C. M., Connelly, J. B., Hewison, J., Robinson, M. B., & Pearman, A. D. (1999). Informed decision making: an annotated bibliography and systematic review. Health Technology and Assessments, 3(1), 1–156.
5. Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., & Kingsmore, S. F. (2011). Carrier testing for severe childhood recessive diseases by next-generation sequencing. Science Translational Medicine, 3(65), 65ra4. doi: 10.1126/scitranslmed.3001756 .